Clinical Trial Update: Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer Asthenia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial assessing the clinical efficacy and safety of Nuvastatic for cancer-related asthenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthenia
• Cancer

Drugs mentioned

• Nuvastatic

Snippet

Sponsor: Natureceuticals Sdn Bhd | Conditions: Asthenia, Cancer | Phase 2, Phase 3 | Status: COMPLETED